OurCrowd portfolio company SaNOtize says that a UK clinical trial has delivered solid results as COVID-19 treatment. A self-administered nasal spray is said to reduce the viral load by more than 95% in 24 hours and by 99% in 72 hours. Trial results indicated that treatment accelerated clearance of SARS-CoV-2 by a factor of 16-fold versus a placebo.

Read more here.